Literature DB >> 22750506

Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides.

Corinne Lebreton1, Sandrine Ménard1, Juliette Abed1, Ivan Cruz Moura2, Rosanna Coppo3, Christophe Dugave4, Renato C Monteiro2, Aurélie Fricot5, Meriem Garfa Traore6, Martin Griffin7, Christophe Cellier8, Georgia Malamut8, Nadine Cerf-Bensussan9, Martine Heyman1.   

Abstract

BACKGROUND & AIMS: The transferrin receptor (CD71) is up-regulated in duodenal biopsy samples from patients with active celiac disease and promotes retrotransport of secretory immunoglobulin A (SIgA)-gliadin complexes. We studied intestinal epithelial cell lines that overexpress CD71 to determine how interactions between SIgA and CD71 promote transepithelial transport of gliadin peptides.
METHODS: We analyzed duodenal biopsy specimens from 8 adults and 1 child with active celiac disease. Caco-2 and HT29-19A epithelial cell lines were transfected with fluorescence-labeled small interfering RNAs against CD71. Interactions among IgA, CD71, and transglutaminase 2 (Tgase2) were analyzed by flow cytometry, immunoprecipitation, and confocal microscopy. Transcytosis of SIgA-CD71 complexes and intestinal permeability to the gliadin 3H-p31-49 peptide were analyzed in polarized monolayers of Caco-2 cells.
RESULTS: Using fluorescence resonance energy transfer and in situ proximity ligation assays, we observed physical interactions between SIgA and CD71 or CD71 and Tgase2 at the apical surface of enterocytes in biopsy samples and monolayers of Caco-2 cells. CD71 and Tgase2 were co-precipitated with SIgA, bound to the surface of Caco-2 cells. SIgA-CD71 complexes were internalized and localized in early endosomes and recycling compartments but not in lysosomes. In the presence of celiac IgA or SIgA against p31-49, transport of intact 3H-p31-49 increased significantly across Caco-2 monolayers; this transport was inhibited by soluble CD71 or Tgase2 inhibitors.
CONCLUSIONS: Upon binding to apical CD71, SIgA (with or without gliadin peptides) enters a recycling pathway and avoids lysosomal degradation; this process allows apical-basal transcytosis of bound peptides. This mechanism is facilitated by Tgase2 and might be involved in the pathogenesis of celiac disease.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22750506     DOI: 10.1053/j.gastro.2012.05.051

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  39 in total

Review 1.  Role of secretory IgA in the mucosal sensing of commensal bacteria.

Authors:  Amandine Mathias; Bruno Pais; Laurent Favre; Jalil Benyacoub; Blaise Corthésy
Journal:  Gut Microbes       Date:  2014

2.  Celiac disease: a challenging disease for pharmaceutical scientists.

Authors:  Simon Matoori; Gregor Fuhrmann; Jean-Christophe Leroux
Journal:  Pharm Res       Date:  2012-12-11       Impact factor: 4.200

Review 3.  Immunogenetic Pathogenesis of Celiac Disease and Non-celiac Gluten Sensitivity.

Authors:  Celia Escudero-Hernández; Amado Salvador Peña; David Bernardo
Journal:  Curr Gastroenterol Rep       Date:  2016-07

Review 4.  Biomarkers and targeted new therapies for IgA nephropathy.

Authors:  Rosanna Coppo
Journal:  Pediatr Nephrol       Date:  2016-06-20       Impact factor: 3.714

Review 5.  The mucosa-kidney axis in IgA nephropathy.

Authors:  Jürgen Floege; John Feehally
Journal:  Nat Rev Nephrol       Date:  2015-12-30       Impact factor: 28.314

6.  Abnormal apical-to-basal transport of dietary ovalbumin by secretory IgA stimulates a mucosal Th1 response.

Authors:  J Abed; C Lebreton; G Champier; A Cuvillier; M Cogné; B Meresse; C Dugave; M Garfa-Traoré; B Corthésy; N Cerf-Bensussan; M Heyman
Journal:  Mucosal Immunol       Date:  2013-07-10       Impact factor: 7.313

Review 7.  Latest in vitro and in vivo models of celiac disease.

Authors:  Samantha Stoven; Joseph A Murray; Eric V Marietta
Journal:  Expert Opin Drug Discov       Date:  2013-01-08       Impact factor: 6.098

Review 8.  Current and emerging therapies for coeliac disease.

Authors:  Laura Kivelä; Alberto Caminero; Daniel A Leffler; Maria Ines Pinto-Sanchez; Jason A Tye-Din; Katri Lindfors
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-11-20       Impact factor: 46.802

Review 9.  Role of IgA receptors in the pathogenesis of IgA nephropathy.

Authors:  Sebastian M Lechner; Christina Papista; Jonathan M Chemouny; Laureline Berthelot; Renato C Monteiro
Journal:  J Nephrol       Date:  2015-11-14       Impact factor: 3.902

Review 10.  Immunopathogenesis and therapeutic approaches in pediatric celiac disease.

Authors:  Shreya Agarwal; Oormila Kovilam; Terence L Zach; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2016-04-01       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.